原发性肝癌的临床表现常不一致,病理基础亦多差异,对各种治疗的反应相差悬殊。故多年来许多学者都希望有一个统一的分型分期方案,以利选择治疗、评价疗效和估计预后。但至今曾试用的种种方案皆觉尚不完善. The clinical manifestations of primary liver cancer are often inconsistent, the pathological basis is also different, and the response to various treatments is very different. Therefore, for many years, many scholars hope to have a unified classification scheme to facilitate the selection of treatment, evaluation of efficacy, and estimation of prognosis. However, all the programs tried so far are still not perfect.